CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net income	$ 18,958	$ 151,576
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	679	(6,788)
Depreciation and amortization	2,909	3,027
Write down of other real estate, net of gain on sale	(457)	(7,739)
Amortization of other intangible assets	2,558	4,357
Net amortization of investment securities	4,160	7,618
Share-based compensation	813	1,606
Net gain on investment securities	(240)
Net gain on sales of residential loans	(2,466)	(7,016)
Proceeds from sales of loans held for sale	177,204	398,955
Originations of loans held for sale	(170,832)	(368,330)
Equity in earnings of unconsolidated subsidiaries	(411)	(220)
Increase in cash surrender value of bank-owned life insurance	(1,638)	(881)
Deferred income taxes	9,438	(117,857)
Net change in other assets and liabilities	(5,119)	17,240
Net cash provided by operating activities	35,556	75,548
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	66,804	289,045
Proceeds from sales of investment securities available for sale	162,470
Purchases of investment securities available for sale	(18,989)	(414,486)
Proceeds from maturities of and calls on investment securities held to maturity	7,098	6,174
Purchases of investment securities held to maturity	(2,443)
Net loan originations	(143,303)	(149,091)
Purchase of loan portfolio	(22,690)	(26,235)
Proceeds from sales of loans originated for investment		460
Proceeds from sale of other real estate	1,884	14,205
Purchases of premises and equipment	(2,573)	(3,075)
Distributions from unconsolidated subsidiaries	396	550
Contributions to unconsolidated subsidiaries	466	(9,050)
Proceeds from redemption of FHLB stock	1,182	869
Net cash provided by (used in) investing activities	50,302	(290,634)
Cash flows from financing activities:
Net increase in deposits	66,405	174,894
Repayments of long-term debt	(9)	(9)
Net increase in short-term borrowings	20,985
Cash dividends paid on common stock	(6,251)
Repurchases of common stock and other related costs	(129,391)
Net proceeds from issuance of common stock and stock option exercises	74
Net cash provided by (used in) financing activities	(48,187)	174,885
Net increase (decrease) in cash and cash equivalents	37,671	(40,201)
Cash and cash equivalents at beginning of period	49,348	177,375
Cash and cash equivalents at end of period	87,019	137,174
Cash paid during the period for:
Interest	3,283	15,666
Income taxes		5
Cash received during the period for:
Income taxes	79
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	11	39
Net reclassification of loans to other real estate	1,511	3,217
Net transfer of investment securities available for sale to held to maturity		$ 101,669

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.